Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02615990
Other study ID # Erigo 15-0519
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date November 2016
Est. completion date November 2016

Study information

Verified date April 2018
Source University of Kentucky
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will assess the effects of the Erigo applied as part of the early mobilization program in the Trauma ICU at the University of Kentucky. It is our hypothesis, that with the Erigo, critically ill patients will tolerate verticalization and mobilization earlier and safely resulting in improved outcomes measured by increased mobility and strength on ICU discharge, decreased requirements for mechanical ventilation, reduced complication rates and decreased ICU and hospital LOS.


Description:

The "Erigo" by Hocoma is a combination of tilt table with a robotic stepper device allowing for cyclic leg loading. Erigo now also includes Functional Electrical Stimulation to optimize active neuromuscular stimulation. It allows for protected gradual verticalization and mobilization based on patient tolerance and progress. It has been shown to improve orthostatic tolerance, cerebral blood flow and muscle strength.

Prospective Randomized Controlled Trial will compare two groups. The patients that meet inclusion criteria will be randomized into either the treatment group or a control group. General ICU mobility guidelines consist of scaled activity related to the patients' stability. The control group will get the general ICU mobility treatments and the treatment group will have one mobility treatment replaced with the Erigo treatment.


Recruitment information / eligibility

Status Terminated
Enrollment 2
Est. completion date November 2016
Est. primary completion date November 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Admission to Trauma ICU

1. Trauma Patients requiring physical therapy (including severe traumatic brain injury or polytrauma without extremity fractures or unstable thoracic or lumbar spine fracture

2. Burn patients requiring physical therapy

3. GI surgery patients requiring physical therapy

4. Necrotizing fasciitis patient requiring physical therapy

Exclusion Criteria:

Patients with the following conditions:

1. Non-weight bearing on lower extremities

2. Untreated DVT

3. Active hemorrhage

4. Leg length >102cm or <72cm

5. Weight >135kg

6. Systolic BP > 20mmHg sustained for 10min

7. Heart rate >20bpm outside goal for more than 20min

8. Intracranial pressure (ICP) >20mmHg sustained for 10min if applicable,

9. Temperature >38.2C

Study Design


Related Conditions & MeSH terms

  • Trauma Patients Requiring Physical Rehabilitation

Intervention

Device:
Erigo Pro
Verticalization table with two integrated robotic devices for leg movement and cyclic loading
Other:
Standard Physical Therapy
Patients receive standard physical therapy.

Locations

Country Name City State
United States University of Kentucky Lexington Kentucky

Sponsors (1)

Lead Sponsor Collaborator
Lisa J. Fryman

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Orthostatic Tolerance During Verticalization Rapid decreases in blood pressure are a common clinical challenge when trauma patients go from lying down to standing. Changes in blood pressure will be compared between groups to determine if verticalization with an ERIGO Pro tilt table will alleviate the drop in blood pressure more quickly than standard of care. Participants will have their blood pressure measured upon initial verticalization after injury and at each treatment session there after until they achieve ambulation (the ability to move without assistance). Data will be presented as the number of days of treatment required to achieve blood pressure homeostasis during the positional change from lying to standing. Up to one year
Primary Orthostatic Tolerance During Ambulation Rapid decreases in blood pressure are a common clinical challenge when trauma patients go from standing to full ambulation. Changes in blood pressure will be compared between groups to determine if verticalization with an ERIGO Pro tilt table will alleviate the drop in blood pressure more quickly than standard of care. Participants will have their blood pressure measured upon initial unassisted standing and then during each treatment session there after until discharge. Data will be presented as the number of days of treatment required to achieve blood pressure homeostasis during the positional change from standing to full ambulation. Up to one year
Secondary ICU Length of Stay The duration of stay in the Trauma ICU will be measured and compared between groups. Data will be presented as mean number of days in the ICU. Up to three months
Secondary Hospital Length of Stay The duration of hospitalization will be measured and compared between groups. Data will be presented as mean number of days the participant is hospitalized. Up to one year
Secondary Incidence of Pneumonia While Hospitalized Incidence of pneumonia while hospitalized will be determined by clinical symptoms to include temperature >100.8 degrees F, WBC>12,000 WBC/mm3 , PaO2/Fio2 ratio < 300 mmHg, positive respiratory culture for organisms and chest x-ray indicative of pneumonia. Total incidence will be compared between groups and presented as a total count of pneumonia diagnoses per group. Up to one year
Secondary Incidence of Urinary Tract Infections While Hospitalized Incidence of urinary tract infection during hospitalization will be determined by clinical symptoms to include temperature of > 100.8 degrees F, WBC> 12000 WBC/MM3, patient complaints of pain, positive urine culture. Total incidence will be compared between groups and presented as a total count of urinary tract infection diagnoses per group. Up to one year
Secondary Incidence of Deep Vein Thrombosis (DVT) Incidence of DVT with be determined based on clinical symptoms to include pain and positive duplex ultrasound or other diagnostic tool Up to one year
Secondary Incidence of Pressure Ulcers Incidence of pressure ulcers determined by physical observation. Total incidence will be compared between groups and presented as a total count of pressure ulcer diagnoses per group. Up to one year
Secondary Incidence of Physical Instability Incidence of physical instability with be calculated as the number of falls per participant while hospitalized. Data will be presented as the number of falls per participant per group. Up to one year
Secondary Incidence of Catheter Disruption Incidence of unplanned removal/displacement of lines/tubes/catheters. Data will be presented as the number of disruptions per participant per group. Up to one year
Secondary Measure of Physical Capacity Kansas University Hospital Physical Therapy Acute Care Functional Outcome Tool will be utilized to assess the participant's overall physical function prior to discharge. . Total score: 0 - 32, usually divided by 25%, 50%, >75% (minimum, moderate, maximum functionality). The higher the score, the great physical function the participant has. At discharge (up to 1 year)
Secondary Measure of Muscle Power The Muscle Research Council Muscle Scale will be used to determine actual muscle power generation vs the anticipated power generation prior to discharge. Total score: 0 - 5, 5 is normal muscle function. Data are presented as units on a scale. Up to one year
Secondary Fall Risk Participant fall risk will be determined prior to discharge using the Berg Balance Scale to assess impairment of balance function through the completion of several functional tasks. The data are presented as units on a scale. The higher the number the lower the fall risk. Up to one year
Secondary Assessment of Participant Mobility The ICU Mobility Scale ranks a participant's mobility on a scale of 0-32, were a score of zero is a completely non-mobile individual and a score of 32 is a fully ambulatory individual. Data will be collected at the time of discharge. The data are presented as units on a scale. Up to one year
Secondary Independent Ambulation The number of hospital days required for the participant to regain independent ambulation (the ability to walk 5 meters unassisted) with be measured and presented as total days. Up to one year
Secondary Mid-leg Muscle Circumference Mid-leg muscle circumference will be measure using a metric tape measure at hospital admission and again just prior to discharge. Data will be presented as the change in muscle circumference (cm) over time. Up to one year
Secondary Number of Patients Discharged From Hospital to Home The number of participants discharged to their home will be counted and presented as a percentage of the total participants in that arm. Up to one year
Secondary Number of Patients Discharged From Hospital to Skilled Nursing Facility The number of participants discharged to a skilled nursing home will be counted and presented as a percentage of the total participants in that arm. Up to one year
Secondary Number of Patients Discharged From Hospital to a Long Term Care Facility The number of participants discharged to a long term care facility will be counted and presented as a percentage of the total participants in that arm. Up to one year
Secondary Number of Patients Discharged From Hospital to an Acute Rehabilitation Facility The number of participants discharged to am acute rehabilitation facility will be counted and presented as a percentage of the total participants in that arm. Up to one year